Bayer recently announced that the U.S. Food and Drug Administration approved Lynkuet® (elinzanetant), the first dual ...

Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...

Bayer (XTRA:BAYN) shares have seen modest movement lately, attracting investor attention due to underlying shifts in the ...

WHIPPANY, N.J.--(BUSINESS WIRE)--On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple ...

Bayer BAYRY hosted a pharmaceutical research and development presentation that did not impact our fair value estimate but provided more details around earlier-stage assets that will be important in ...

In the aftermath of devastating wildfires on Maui, Bayer is standing up as one of the first pharmaceutical companies to offer relief. The German conglomerate is providing a cash donation of $250,000 ...

Bayer AG is considering doing deals in the range of €1 billion to €5 billion ($1.1 billion to $5.5 billion) as the drugmaker seeks to rebuild its pipeline of new medicines. Top drugs are losing ...

Vincerx Pharma Inc. company and executive profile by Barron's. View the latest VINC company infomation and executive bios.

A U.S. court reinstated a $185 million verdict over chemical contamination at a Washington state school on Thursday, ...

Aurobindo Ltd. and Aurobindo USA were hit with a patent infringement lawsuit on Oct. 9 in Delaware District Court. The action, brought by McCarter & English and Arnold & Porter Kaye Scholer on behalf ...